Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Clark Health Communications make three team additions

Announcements coincides with its Communiqué Awards nominations

- PMLiVE

Patrick Fabbio named CFO at electroCore

He joins from NPS Pharmaceuticals where he was VP finance

- PMLiVE

MRC Technology and Peptinnovate join on bone disease

Firms aim to discovery a therapy using natural peptides 

EISAI

Eisai launches thyroid cancer therapy Lenvima in UK

The UK is its first European market, with wider EU roll out expected in coming months

- PMLiVE

Receptos rejected AZ takeover bid, say sources

Sources also claim the Delaware-based firm is being chased by Gilead Sciences and Teva

- PMLiVE

Four Communications acquires MSA Media

Takeover will create Four MSA

- PMLiVE

Building and retaining great talent

Consultants at Ashfield discuss how to hold on to your best talent

Biomarin

BioMarin files muscular dystrophy drug in EU

Drisapersen could be the first ‘exon-skipping’ therapy

- PMLiVE

Red Door Unlimited appoints senior consultants

Jock McEwan and Gill Dunn join the firm in digital roles

- PMLiVE

Patient survey finds pharma falls short on drug pricing

The industry is coming under increasing attack from all sides as price tags rise

- PMLiVE

Sanofi will resubmit Lyxumia for FDA approval in Q3

Follows the GLP-1 agonist's all-clear by ELIXA cardiovascular safety study

- PMLiVE

Merck & Co’s diabetes drug Januvia cleared by CV safety trial

Concerns over the DPP-4 inhibitor 'put to bed' by TECOS cardiovascular trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links